Quarterly report [Sections 13 or 15(d)]

Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.25.3
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Share Capital
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2023 $ 302,182 $ 19,881 $ 3,718 $ (250,911) $ 74,870
Beginning Balance (in shares) at Dec. 31, 2023 270,898,900        
Shares issued for cash $ 4,227       4,227
Shares issued for cash (in shares) 2,464,500        
Share issue costs $ (106)       (106)
Exercise of warrants $ 15,849       15,849
Exercise of warrants (in shares) 8,188,250        
Exercise of stock options $ 61 (21)     40
Exercise of stock options (in shares) 74,674        
Stock compensation   324     324
Comprehensive income (loss)     283 (18,541) (18,258)
Ending Balance at Mar. 31, 2024 $ 322,213 20,184 4,001 (269,452) 76,946
Ending Balance (in shares) at Mar. 31, 2024 281,626,324        
Beginning Balance at Dec. 31, 2023 $ 302,182 19,881 3,718 (250,911) 74,870
Beginning Balance (in shares) at Dec. 31, 2023 270,898,900        
Comprehensive income (loss)         (32,769)
Ending Balance at Sep. 30, 2024 $ 412,884 19,192 4,076 (284,038) 152,114
Ending Balance (in shares) at Sep. 30, 2024 363,796,235        
Beginning Balance at Mar. 31, 2024 $ 322,213 20,184 4,001 (269,452) 76,946
Beginning Balance (in shares) at Mar. 31, 2024 281,626,324        
Shares issued for cash $ 22,419       22,419
Shares issued for cash (in shares) 13,108,525        
Share issue costs $ (700)       (700)
Exercise of stock options $ 366 (112)     254
Exercise of stock options (in shares) 449,879        
Stock compensation   325     325
Comprehensive income (loss)     98 (6,584) (6,486)
Ending Balance at Jun. 30, 2024 $ 344,298 20,397 4,099 (276,036) 92,758
Ending Balance (in shares) at Jun. 30, 2024 295,184,728        
Shares issued for cash $ 70,922       70,922
Shares issued for cash (in shares) 67,089,300        
Share issue costs $ (3,877)       (3,877)
Exercise of stock options $ 1,541 (186)     1,355
Exercise of stock options (in shares) 1,522,207        
Redemption of RSUs   (56)     (56)
Reclassify stock options to liabilities   (1,310)     (1,310)
Stock compensation   347     347
Comprehensive income (loss)     (23) (8,002) (8,025)
Ending Balance at Sep. 30, 2024 $ 412,884 19,192 4,076 (284,038) 152,114
Ending Balance (in shares) at Sep. 30, 2024 363,796,235        
Beginning Balance at Dec. 31, 2024 $ 413,242 19,468 4,189 (304,100) 132,799
Beginning Balance (in shares) at Dec. 31, 2024 364,101,038        
Exercise of stock options $ 405 213     618
Exercise of stock options (in shares) 464,807        
Redemption of RSUs $ 283 (343)     (60)
Redemption of RSUs (in shares) 253,415        
Stock compensation   668     668
Comprehensive income (loss)     (28) (10,898) (10,926)
Ending Balance at Mar. 31, 2025 $ 413,930 20,006 4,161 (314,998) 123,099
Ending Balance (in shares) at Mar. 31, 2025 364,819,260        
Beginning Balance at Dec. 31, 2024 $ 413,242 19,468 4,189 (304,100) $ 132,799
Beginning Balance (in shares) at Dec. 31, 2024 364,101,038        
Exercise of stock options (in shares)         1,260,561
Comprehensive income (loss)         $ (59,172)
Ending Balance at Sep. 30, 2025 $ 430,219 19,539 4,334 (363,417) 90,675
Ending Balance (in shares) at Sep. 30, 2025 375,852,609        
Beginning Balance at Mar. 31, 2025 $ 413,930 20,006 4,161 (314,998) 123,099
Beginning Balance (in shares) at Mar. 31, 2025 364,819,260        
Stock compensation   (123)     (123)
Comprehensive income (loss)     73 (20,956) (20,883)
Ending Balance at Jun. 30, 2025 $ 413,930 19,883 4,234 (335,954) 102,093
Ending Balance (in shares) at Jun. 30, 2025 364,819,260        
Shares issued for cash $ 15,168       15,168
Shares issued for cash (in shares) 9,980,095        
Share issue costs $ (379)       (379)
Exercise of warrants $ 501       501
Exercise of warrants (in shares) 257,500        
Exercise of stock options $ 999 (46)     953
Exercise of stock options (in shares) 795,754        
Stock option liability adjustment   (298)     (298)
Comprehensive income (loss)     100 (27,463) (27,363)
Ending Balance at Sep. 30, 2025 $ 430,219 $ 19,539 $ 4,334 $ (363,417) $ 90,675
Ending Balance (in shares) at Sep. 30, 2025 375,852,609